Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39,045 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immortal Time Bias-Corrected Effectiveness of Traditional Chinese Medicine in Non-Small Cell Lung Cancer (C-EVID): A Prospective Cohort Study.
Zhang X, Guo Q, Li C, Liu R, Xu T, Jin Z, Xi Y, Qin Y, Li W, Chen S, Xu L, Lin L, Shao K, Wang S, Xie Y, Sun H, Li P, Chu X, Chai K, Shu Q, Liu Y, Zhang Y, Hu J, Shi B, Zhang X, Zhang Z, Jiang J, He S, He J, Sun M, Zhang Y, Zhang M, Zheng H, Hou W, Hua B. Zhang X, et al. Among authors: xu l, xu t. Front Oncol. 2022 Apr 22;12:845613. doi: 10.3389/fonc.2022.845613. eCollection 2022. Front Oncol. 2022. PMID: 35530347 Free PMC article.
Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial.
Wang Q, Jiao L, Wang S, Chen P, Bi L, Zhou D, Yao J, Li J, Chen Z, Jia Y, Zhang Z, Shen W, Zhu W, Xu J, Gao Y, Gong Y, Xu L. Wang Q, et al. Among authors: xu l, xu j. Front Pharmacol. 2018 Nov 6;9:1233. doi: 10.3389/fphar.2018.01233. eCollection 2018. Front Pharmacol. 2018. PMID: 30459612 Free PMC article.
Chinese Herbal Medicine (Yiqi-Yangyin-Jiedu Decoction) Combined With Osimertinib as First-Line Treatment in EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer (CATLA-2): A Study Protocol for a Double-Blind Randomized Controlled Trial.
Yao J, Lu Y, Jiao L, Bi L, Yang W, Su L, Shi J, Wang Z, Gong Y, Xu L. Yao J, et al. Among authors: xu l. Front Pharmacol. 2022 Apr 1;13:840889. doi: 10.3389/fphar.2022.840889. eCollection 2022. Front Pharmacol. 2022. PMID: 35431966 Free PMC article.
[Traditional Chinese medicine for cancer pain].
Wang JY, Xu L, Zhang RX, Lao L. Wang JY, et al. Among authors: xu l. Zhong Xi Yi Jie He Xue Bao. 2011 Feb;9(2):129-34. doi: 10.3736/jcim20110202. Zhong Xi Yi Jie He Xue Bao. 2011. PMID: 21288445 Review. Chinese.
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients.
Xu L, Li H, Xu Z, Wang Z, Liu L, Tian J, Sun J, Zhou L, Yao Y, Jiao L, Su W, Guo H, Chen P, Liu J. Xu L, et al. Among authors: xu z. BMC Complement Altern Med. 2012 Aug 1;12:112. doi: 10.1186/1472-6882-12-112. BMC Complement Altern Med. 2012. PMID: 22853619 Free PMC article. Clinical Trial.
39,045 results
You have reached the last available page of results. Please see the User Guide for more information.